Unchained Labs Unveils LEA 9 Software Making Workflows Easy
Image credit: Unchained Labs
Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, has now released its LEA 9 software, making Freeslate and Junior automation systems way more accessible.
LEA, short for Laboratory Execution and Analysis Software, controls Freeslate and Junior systems, executes biologics and chemistry workflow designs, integrates third-party tools, and keeps all the data in one place.
LEA 9 adds a step-by-step workflow tool called Design Creator into the mix. There’s no coding, scripting or messing around with protocols. Scientists just drag and drop their workflow steps into place and they’re good to go. Design Creator also double checks each step to make sure it’s doable, so newbie users don’t have to worry about screwing things up.
“Freeslate and Junior already help researchers wipe out major hassles from their toughest workflows,” said Taegen Clary, VP of Marketing at Unchained Labs. “Automation can be insanely complicated, and really nerve wracking for casual users. LEA 9 makes lab automation totally easy and approachable for anyone.”
This article has been republished from materials provided by Unchained Labs. Note: material may have been edited for length and content. For further information, please contact the cited source.
Scientists Report The Development of a Potent New Medicine to Fight AddictionNews
Scientists report the development of a potent new medicine to fight addiction.READ MORE
Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain TherapeuticsNews
The new Swiss company will operate in Lugano and Barcelona under the scientific management of Minoryx co-founder Dr Xavier Barril.READ MORE
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.